JPRN-UMIN000005513尚未招募未知
An exploratory study to evaluate primary systemic therapy in breast cancer using photoacoustic mammography - An exploratory study on photoacoustic mammography
Graduate School of Medicine Kyoto University0 个研究点目标入组 15 人开始时间: 2011年4月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Patients who have taken photosensitizer for photodynamic therapy 2. Patients with cardiac pacemakers 3. Patients with breast implants 4. Patients who are in poor general status 5. Patients who are pregnancy, suspicion of pregnancy, or lactating 6. Patients who are judged ineligible to enroll into this clinical study due to any reasons by the doctor
研究者
相似试验
招募中
不适用
Safety and bioavailability of Somal in CancerCTRI/2018/04/013072Rasayani Cancer Clinics Pune
尚未招募
Unknown
A prospective, single-center investigation of the safety and feasibility of a novel Microwave Ablation SystemC34C78.0Malignant neoplasm of bronchus and lungSecondary malignant neoplasm of lungDRKS00032463Intuitive Surgical30
已完成
不适用
Safety and clinical effects of IDX320 in Hepatitis C infectioGenotype 1 Chronic Hepatitis CInfections and InfestationsChronic viral hepatitisISRCTN44746369Idenix Pharmaceuticals (USA)88
进行中（未招募）
1 期
A first-in-human trial of IDX21437, a new study drug being evaluated for hepatitis C virus infection.Hepatitis C virusMedDRA version: 16.1Level: LLTClassification code 10019751Term: Hepatitis C virusSystem Organ Class: 100000004848EUCTR2013-004043-23-BEIdenix Pharmaceuticals Inc.
进行中（未招募）
不适用
A Phase I/IIa Study Assessing Single and Multiple Doses of HCV Protease Inhibitor IDX320 in Healthy and Genotype 1 HCV-Infected SubjectsHealthy Volunteers and Genotype 1 HCV infectionMedDRA version: 12.1Level: LLTClassification code 10008912Term: Chronic hepatitis CEUCTR2009-018079-15-HUIdenix Pharmaceuticals, Inc84